Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers

NCT01741519 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LDLL600
DRUG: Brevibloc

Sponsor

AOP Orphan Pharmaceuticals AG